Christopher Ogurchak, PharmD, MSPBA Candidate

Remaining special in the specialty pharmacy space requires innovation.

Specialty pharmacies must be prepared to innovate as biosimilars hit the US market.

Specialty pharmacy providers are uniquely positioned to capture information on a wide array of outcomes.

Specialty pharmacies must engage each individual patient to ensure optimal treatment outcomes.

Prescribers and patients can no longer blindly rely on simple and straightforward drug delivery in specialty pharmacy.

Optimal channel selection should be made with the patient’s best interest at the center of the decision.